ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1939

Sinonasal Sarcoidosis Associated with Chronic Pulmonary Disease, Deficiency Anemias, and Obesity

Emily Kokush, Mary Salim, Eugenio Capitle, Reena Khianey and Evelyne Kalyoussef, Rutgers New Jersey Medical School, Newark, NJ

Meeting: ACR Convergence 2023

Keywords: obesity, Qualitative Research

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (1913–1944) Miscellaneous Rheumatic & Inflammatory Diseases Poster III

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Sarcoidosis is a systemic granulomatous inflammatory disease that can involve multiple organ systems. Rarely, sarcoidosis can involve the upper respiratory tract including the sinonasal region. Symptoms easily mimic those of allergic or atrophic rhinitis, bacterial sinusitis; therefore, commonly leading to misdiagnosis. Here, we aim to identify comorbidities in this subset of sarcoidosis patients to raise a higher clinical suspicion for this diagnosis in a higher risk population; thereby, avoiding a delay in appropriate management.

Methods: The National Inpatient Sample (NIS) from 2003 to 2014 was queried to identify patients diagnosed with sarcoidosis (ICD-9: 135). Patients with sarcoidosis were categorized into two groups based on whether they had comorbid sinonasal diagnoses (including acute or chronic sinusitis, nasal polyps, deviated nasal septum, epistaxis, or nasal mucositis). Univariate and multivariate logistic analyses were conducted to compare patient and hospital characteristics as well as Elixhauser comorbidities between the two groups.

Results: A total of 173,236 sarcoidosis patients were included, 5,127 (3.0%) of whom had a comorbid SN diagnosis. Patients with SN involvement were younger (55.09 years ± 13.45 vs 56.15 ± 13.87, p< .001), more often female (70.5% vs 65.8%) than their non-SN counterparts. After accounting for demographics, patients who developed SN diagnoses were more likely to have chronic pulmonary disease (OR [95% CI]: 1.168 [1.093-1.249], p< 0.001), deficiency anemia (1.171 [1.083-1.267], p< 0.001), and be obese (1.228 [1.136-1.329], p< 0.001). However, those with congestive heart failure (0.869 [0.785-0.963], p=0.008), diabetes (0.872 [0.810-0.939], p< 0.001), or renal failure (0.833 [0.752-0.923], p< 0.001) were less likely to have a SN comorbidity. Patients with SN involvement had decreased hospital charges ($36,400 ± $52,672 vs $38,229 ± $62,562, p=0.041), but did not significantly differ on length of stay (5.42 ± 6.71 vs 5.51 ± 6.8, p=0.357) than those without a SN diagnosis. Patients with SN involvement of sarcoidosis were also less likely to die during their hospital admission than their non-SN counterparts (0.603[.457-.795], p< 0.001) (table 1).

Conclusion: Our findings suggest that the management of sarcoidosis patients with chronic pulmonary disease, deficiency anemia, or obesity should include a high index of suspicion for comorbid SN diagnoses. However, SN involvement does not increase sarcoid patients’ risk for death, prolonged stay, or increased hospital charges. Further research is warranted to investigate underlying mechanisms and clinical implications of SN involvement in sarcoidosis.

Supporting image 1


Disclosures: E. Kokush: None; M. Salim: None; E. Capitle: None; R. Khianey: None; E. Kalyoussef: None.

To cite this abstract in AMA style:

Kokush E, Salim M, Capitle E, Khianey R, Kalyoussef E. Sinonasal Sarcoidosis Associated with Chronic Pulmonary Disease, Deficiency Anemias, and Obesity [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/sinonasal-sarcoidosis-associated-with-chronic-pulmonary-disease-deficiency-anemias-and-obesity/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/sinonasal-sarcoidosis-associated-with-chronic-pulmonary-disease-deficiency-anemias-and-obesity/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology